Merge Healthcare
About Us Press Room Investor Relations Human Resources Contact Us
Press Room
 

Merge Technologies Acquires Assets of Aurora Technology, Inc. Merge welcomes several new customers, distribution channel partners and an expanded product offering.
Milwaukee, WI, June 6, 2002

Milwaukee, WI, June 5, 2002 - Merge Technologies Incorporated (NASDAQ: MRGE) today announced that it has acquired the assets of Aurora Technology, Inc., a private Minnesota corporation with operations in Lake Bluff, Illinois, for 93,901 shares of common stock plus $100,000 in cash. Aurora develops and markets medical imaging and information workflow products.

Richard Linden, Merge's President and CEO, said, "We are pleased to have the Aurora team, their customers and distribution partners join the expanding Merge family. Aurora's current customers represent various types of prestigious end-user clinical environments, from small imaging centers to multi-facility organizations and large teaching hospitals. We welcome these new customers to our growing installed base."


"As an Aurora customer, we are pleased by this acquisition," said Jerry Rice, Vice President of Operations at Gurnee Radiology Center. "The depth and breadth of Merge's modular software and service-based offering is ideal for a growing organization like ours. We have been very pleased with the performance of Aurora and look forward to expanding our relationship with Merge."

Dr. Joseph Ferrucci, M.D., Chairman of Radiology at Boston Medical Center, an Aurora customer, acknowledged the positive impact of the acquisition. "Service and support is crucial to our operations," said Dr. Ferrucci. "Merge's history and reputation in that arena are outstanding, and we are pleased to know we have an reliable partner that is committed to its customers. Those are important factors in our future relationship."

"As a practicing Radiologist, products that reflect knowledge and understanding of clinical radiology are of utmost importance," said Dr. TTTTH. MacMahon, M.D., Chairman of Radiology at the University of Chicago Hospitals and Health System. "We have a long-standing cooperative relationship with Aurora and have utilized its workstations for many years. Merge has built a reputation for the integration of clinical and IT disciplines. That is the kind of organization with whom we would like to grow our practice."

Press Contact

Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214

Phone:
1-(414) 977-4254

Email Address: marketing@merge.com
Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.